796070-75-2 Usage
Uses
Used in Pharmaceutical Industry:
2-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)aniline(SALTDATA: FREE) is used as an intermediate in the synthesis of various pharmaceutical compounds for its ability to contribute to the development of biologically active molecules.
Used in Dye Industry:
In the dye industry, 2-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)aniline(SALTDATA: FREE) is utilized as a building block for the preparation of dyes, leveraging its chemical properties to create a range of colorants.
Used in Agrochemical Production:
2-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)aniline(SALTDATA: FREE) is employed as a precursor in the production of agrochemicals, playing a crucial role in the development of effective agricultural products.
Used in Organic Synthesis:
As a reagent in organic synthesis, 2-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)aniline(SALTDATA: FREE) is used to facilitate various chemical reactions, contributing to the creation of a wide array of organic compounds for different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 796070-75-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,6,0,7 and 0 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 796070-75:
(8*7)+(7*9)+(6*6)+(5*0)+(4*7)+(3*0)+(2*7)+(1*5)=202
202 % 10 = 2
So 796070-75-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H11N3O/c1-6-3-4-8(5-9(6)11)10-13-12-7(2)14-10/h3-5H,11H2,1-2H3
796070-75-2Relevant academic research and scientific papers
THERAPEUTIC AGENT FOR CEREBRAL INFARCTION
-
, (2012/08/08)
The invention provides a therapeutic drug for ischemic stroke. The therapeutic drug has the formula (I) wherein each symbol is as defined herein, or a pharmacologically acceptable salt thereof, or a solvate thereof, as an active ingredient.
PHENYL-ANILINE SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS KINASE INHIBITORS
-
Page/Page column 84, (2010/02/11)
Compounds having the formula (I), and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are useful as kinase inhibitors, wherein R, R1 , R2, R5, R6a, R6b, J, K, X and Z are as described in the specification.
